Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Linch

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
British Journal of Haematology|September 20, 2011
Burkitt lymphoma in adultsDavid C Linch
British Journal of Haematology|April 3, 2012
Treatment of the elderly patient with diffuse large B cell lymphomaPaul A Fields, David C Linch
British Journal of Haematology|October 18, 2016
Optimisation and quality control of cell processing for autologous stem cell transplantationMichael J Watts, David C Linch
British Journal of Haematology|June 10, 2008
Most acute myeloid leukaemia patients with intermediate mutant FLT3/ITD levels do not have detectable bi-allelic disease, indicating that heterozygous disease alone is associated with an adverse outcomeClaire Green, David C Linch, Rosemary E Gale
British Journal of Haematology|January 11, 2005
The role of allogeneic transplantation in non-Hodgkin's lymphomaKarl S Peggs, Stephen Mackinnon, David C Linch
Journal of Geriatric Oncology|September 28, 2013
Factors affecting survival in patients aged 60 and over with diffuse large B cell lymphoma failing first-line therapyLisa Lowry, Paul Smith, David Cunningham, et al.
British Journal of Haematology|March 5, 2003
Different levels of p38 MAP kinase activity mediate distinct biological effects in primary human erythroid progenitorsTim C P Somervaille, David C Linch, Asim Khwaja
Leukemia & Lymphoma|July 12, 2003
Prognostic implications of the presence of FLT3 mutations in patients with acute myeloid leukemiaPanagiotis D Kottaridis, Rosemary E Gale, David C Linch
British Journal of Haematology|December 21, 2004
A review of gene therapy for haematological disordersAmit C Nathwani, Andrew M Davidoff, David C Linch
British Journal of Haematology|August 6, 2003
Flt3 mutations and leukaemiaPanagiotis D Kottaridis, Rosemary E Gale, David C Linch
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|September 20, 2011
Burkitt lymphoma in adultsDavid C Linch
British Journal of Haematology|April 3, 2012
Treatment of the elderly patient with diffuse large B cell lymphomaPaul A Fields, David C Linch
British Journal of Haematology|October 18, 2016
Optimisation and quality control of cell processing for autologous stem cell transplantationMichael J Watts, David C Linch
British Journal of Haematology|June 10, 2008
Most acute myeloid leukaemia patients with intermediate mutant FLT3/ITD levels do not have detectable bi-allelic disease, indicating that heterozygous disease alone is associated with an adverse outcomeClaire Green, David C Linch, Rosemary E Gale
British Journal of Haematology|January 11, 2005
The role of allogeneic transplantation in non-Hodgkin's lymphomaKarl S Peggs, Stephen Mackinnon, David C Linch
Journal of Geriatric Oncology|September 28, 2013
Factors affecting survival in patients aged 60 and over with diffuse large B cell lymphoma failing first-line therapyLisa Lowry, Paul Smith, David Cunningham, et al.
British Journal of Haematology|March 5, 2003
Different levels of p38 MAP kinase activity mediate distinct biological effects in primary human erythroid progenitorsTim C P Somervaille, David C Linch, Asim Khwaja
Leukemia & Lymphoma|July 12, 2003
Prognostic implications of the presence of FLT3 mutations in patients with acute myeloid leukemiaPanagiotis D Kottaridis, Rosemary E Gale, David C Linch
British Journal of Haematology|December 21, 2004
A review of gene therapy for haematological disordersAmit C Nathwani, Andrew M Davidoff, David C Linch
British Journal of Haematology|August 6, 2003
Flt3 mutations and leukaemiaPanagiotis D Kottaridis, Rosemary E Gale, David C Linch
Pageof 13